just wait till these hit...Yikes. Happening a little less than a year but yikes!!
During the quarter ended March 31, 2015 Regen Biopharma, Inc. issued Convertible Notes ( “Notes”) with an aggregate face value of $882,686 . Consideration for these Notes consisted of:
(a) $775,000 cash and
(b) Satisfaction of $107,686 of existing indebtedness:
Each Note becomes due and payable at the demand of the Lender at any time after one year subsequent to the issuance date and bears simple interest at 10% per annum payable quarterly at the demand of the Lender.
IMO
